Meet the team

  • Professor David Adams

  • Professor Graham Anderson focuses on the role of the thymus in T-cell development, including approaches to improve immune reconstitution following ablative

    FIND OUT MORE

    Professor Graham  Anderson

  • Gavin Bendle is focussed on developing TCR gene transfer approaches to treat haematological malignancies, including in particular multiple myeloma.

    FIND OUT MORE

    Dr Gavin Bendle

  • Professor Roy Bicknell is focussed on understanding and therapeutically targeting tumour angiogenesis.

    FIND OUT MORE

    Professor Roy Bicknell

  • David Briggs is a Consultant Clinical Scientist, and head of Histocompatibility and Immunogenetics at NHS Blood and Transplant, Birmingham. He

    FIND OUT MORE

    Professor David Briggs

  • Dr Rik Bryan is a former clinical urologist and now a full-time research academic with a strong interest in bladder cancer.

    FIND OUT MORE

    Dr Rik Bryan

  • Chris Buckley focusses on understanding the immunobiology of the stromal microenvironment, a key therapeutic target for both chronic inflammatory conditions and

    FIND OUT MORE

    Professor Chris Buckley

  • Fred Chen is a consultant haematologist with a strong interest in Stem Cell Transplantation (SCT). Fred is closely involved in clinical

    FIND OUT MORE

    Dr Frederick Chen

  • Mark Cobbold is identifying and characterising the immune response to phosphopeptides, an emerging group of tumour-associated antigens. In addition, his work

    FIND OUT MORE

    Dr Mark Cobbold

  • Dr Mark Cook is a Consultant Haematologist at the Queen Elizabeth Hospital Birmingham (QEHB). Based in the Centre for Clinical Haematology,

    FIND OUT MORE

    Dr Mark Cook

  • Charlie Craddock is working with Dr Ram Malladi and Professor Paul Moss on clinical treatment of haematological malignancies, key approaches being

    FIND OUT MORE

    Professor Charlie Craddock

  • Dr Stuart Curbishley is a liver immunologist who is closely involved in vaccination approaches to target hepatocellular carcinoma, and cell therapy

    FIND OUT MORE

    Dr Stuart Curbishley

  • Dr Carmela De Santo is an expert on tumour immunosuppression, and in particular on myeloid derived suppressor cells.

    FIND OUT MORE

    Dr Carmela  De Santo

  • Mark Drayson leads the Birmingham Clinical Immunology Service (CIS), one of the largest diagnostic immunology services in the UK. The CIS

    FIND OUT MORE

    Professor Mark Drayson

  • Dr Sylvie Freeman is a Clinical Senior Lecturer and Honorary Consultant Haematologist in the departments of Clinical Immunology, University of Birmingham

    FIND OUT MORE

    Dr Sylvie Freeman

  • Dr Andrew Hislop is a viral immunologist with an interest in how T-cells control oncogenic human viruses such as Kaposi sarcoma-associated

    FIND OUT MORE

    Dr Andrew Hislop

  • Dr Dan Hollyman is Head of Stem Cell & Immunotherapies, NHS Blood and Transplant, Birmingham. He has a strong track record

    FIND OUT MORE

    Dr Daniel  Hollyman

  • Professor Roy Jefferis is Professor Emeritus at Uuniversity of Birmingham and an expert on antibody structure and function.

    FIND OUT MORE

    Professor Roy Jefferis

  • Professor Peter Lane is a clinical immunologist whose research focusses on the cellular and molecular mechanisms that modulate the development of

    FIND OUT MORE

    Professor Peter Lane

  • Dr Steven Lee is a Senior Research Fellow whose research is focused on engineering T cells to target human tumours, either

    FIND OUT MORE

    Dr Steven Lee

  • Dr Heather Long’s research is focused on developing immune T cell-based therapies for the treatment of EBV-associated and non-virus associated lymphomas.

    FIND OUT MORE

    Dr Heather Long

  • Ram Malladi is a consultant haematologist based at the Centre for Clinical Haematology, who works closely with Professor Charlie Craddock and

    FIND OUT MORE

    Dr Ram Malladi

  • Professor Hisham Mehanna is a Head and Neck cancer surgeon, who leads an internationally leading portfolio of clinical trials in this

    FIND OUT MORE

    Professor Hisham Mehanna

  • Professor Gary Middleton is a consultant medical oncologist focussed on lung and colorectal cancer, with a research interest in understanding

    FIND OUT MORE

    Professor Gary Middleton

  • Dr Fiyaz Mohammed is a protein crystallographer with a long standing interest in immune receptor structure and function.

    FIND OUT MORE

    Dr Fiyaz Mohammed

  • Dion Morton is Professor of Surgery and is Director of the Experimental Cancer Medicine Centre (ECMC) at the University of Birmingham.

    FIND OUT MORE

    Professor Dion Morton

  • Professor Moss’s research is focussed around the application of translational immunological research in the study of human cancer.

    FIND OUT MORE

    Professor Paul Moss

  • Dr Francis Mussai is a Clinical Senior Lecturer with a strong research interest in exploring the immunosuppressive microenvironment generated by paediatric

    FIND OUT MORE

    Dr Francis Mussai

  • Dr Ye Htun Oo is a Medical Research Council Clinician Scientist and Honorary Consultant Hepatologist at the UHB NHS Foundation Trust,

    FIND OUT MORE

    Dr Ye Oo

  • Dr Guy Pratt is a consultant haematologist with a long-standing research interest in multiple myeloma and chronic lymphocytic leukaemia.

    FIND OUT MORE

    Dr Guy Pratt

  • Manoj Raghavan is a consultant haematologist based at the Centre for Clinical Haematology. Manoj works closely with Professor Charlie Craddock, and

    FIND OUT MORE

    Dr Manoj Raghavan

  • Peter Searle is developing immuno/gene therapy approaches to treat prostate cancer, using modified Adenoviruses and cytokines ; this work is

    FIND OUT MORE

    Dr Peter Searle

  • Professor Tanja Stankovic is characterising the DNA damage response and genome instability in range of haematological malignancies. Her research has led

    FIND OUT MORE

    Professor Tanja Stankovic

  • Neil Steven is a consultant oncologist with a strong interest in immunotherapy clinical trials, particularly in skin cancer, including

    FIND OUT MORE

    Dr Neil Steven

  • Dr Graham Taylor has developed a research portfolio studying the immune response to Epstein Barr Virus, a common pathogen linked

    FIND OUT MORE

    Dr Graham Taylor

  • Dr Daniel Tennant is a Lecturer in Cancer Biochemistry studying hypoxia and cancer metabolism.

    FIND OUT MORE

    Dr Daniel Tennant

  • Dr Kai-Michael Toellner’s research is focused on the basic immunobiology of B cell selection, maturation, and differentiation, as well as in

    FIND OUT MORE

    Dr Kai Toellner

  • Dr Chris Tselepis is a Senior Lecturer at the University of Birmingham with an interest in gut cancer biology. Specifically his

    FIND OUT MORE

    Dr Chris Tselepis

  • Professor Ben Willcox is characterising the immune response to cellular stress antigens, including targets recognised by gamma delta T cells,

    FIND OUT MORE

    Professor Ben Willcox

  • Dr Carrie Willcox is an immunologist with a strong interest in understanding unconventional lymphocyte recognition, and wide experience in molecular and

    FIND OUT MORE

    Dr Carrie Willcox